Surgeons’ Perspectives on Changing the Default Number of Doses for Opioid Prescriptions in Electronic Health Record Systems
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.15633
Abstract: This qualitative study assesses surgeons’ perspectives regarding a change in the default number of doses for opioid prescriptions written through an electronic health record system to adolescents and young adults undergoing tonsillectomy. read more here.
Keywords: doses opioid; number doses; electronic health; surgeons perspectives ... See more keywords
Maximizing number of doses drawn from multi-dose COVID-19 vaccines by minimizing dead-volume
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Travel Medicine"
DOI: 10.1093/jtm/taab049
Abstract: Maximizing number of doses drawn from multi-dose COVID-19 vaccines by minimizing dead-volume Brendan Le Daré, PharmD, PhD1,2,*, Astrid Bacle, PharmD, PhD1,3, Roxane Lhermitte1, François Lesourd, PharmD1, and Yves Lurton, PharmD1 1Centre Hospitalier Universitaire de Rennes,… read more here.
Keywords: number doses; maximizing number; doses drawn; dose covid ... See more keywords
Role of clinical and laboratory parameters for treatment choice in patients with inherited FVII deficiency undergoing surgical procedures: evidence from the STER registry
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Haematology"
DOI: 10.1111/bjh.15055
Abstract: Perioperative bleeding is a major concern in patients with factor VII (FVII) deficiency. Evaluating data of 95 FVII‐deficient patients undergoing 110 surgical procedures (61 major, 49 minor), we assessed the impact of type of surgery,… read more here.
Keywords: fvii deficiency; surgical procedures; number doses; history major ... See more keywords
Dose intensification strategy influences infliximab pharmacokinetics but not clinical response after the same number of doses
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Gastroenterology and Hepatology"
DOI: 10.1111/jgh.16133
Abstract: The optimal infliximab dose intensification strategy to address secondary loss of response (LOR) remains unclear. This study aimed to compare clinical and pharmacokinetic outcomes following (i) upfront infliximab re‐induction with (ii) ongoing 6‐weekly dose interval… read more here.
Keywords: number doses; intensification strategy; response; dose intensification ... See more keywords